documents: FDA-2026-N-12508-0001
Data license: Public Domain (U.S. Government data) · Data source: Regulations.gov API (General Services Administration)
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | comment_end_datetime | perpetual_docket | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2026-N-12508-0001 | FDA | FDA-2026-N-12508 | Hematology and Pathology Devices; Reclassification of Immunohistochemistry Test Systems for Use With a Corresponding Approved Oncology Therapeutic Product | Proposed Rule | Request for Comment | 2026-11-12 | 2026 | 11 | 2026-11-12 | 2027-01-11 | 2027-01-12 04:59:59 | 0 | 2026-11-14 10:00:56 | 2026-23005 | 1 | 0 | 09000064b970f439 |